Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Go Raw LLC Expands Pet Food Recall Over Low Thiamine Levels in Freeze-Dried Chicken Recipe
COTTONWOOD HEIGHTS, Utah – June 8, 2026 – Go Raw LLC has expanded its voluntary recall to include an additional lot of Steve’s Real Food Freeze-Dried Chicken Recipe due to potentially low levels of thiamine (Vitamin B1), the company announced Monday.
The expansion follows a February 17, 2026 recall and affects one lot of the freeze-dried cat and dog food product. The recalled item is sold in beige, zip-locked 1.25 lb. packages with a maroon stripe and UPC 6-91730-18103-1. The affected lot code is C26022 with a Best By Date of 1/22/2028, printed on the front of the bag.
The recall is now being EXPANDED to include the following additional lot:
| Product | Size | Lot Code | UPC | Best Buy Date |
|---|---|---|---|---|
| Steve’s Real Food Chicken Recipe Freeze Dried | 1.25 lb Bag | C26022 | 6-91730-164 02-7 | 1/22/2028 |
Additionally, the company has previously issued a recall of:
| Product | Size | Lot Code | UPC | Best Buy Date |
|---|---|---|---|---|
| Quest Cat Food Chicken Recipe Freeze Dried Nuggets | 10 oz. Bag | C25288 | 6-91730-18103- 1 | 10/15/2027 |
| Quest Cat Food Chicken Recipe Frozen Diet | 2 lb. Bag | MCD25350 | 6-91730-17104- 9 | 6/16/2027 |
| Quest Cat Food Chicken Recipe Frozen Diet | 12 lb. Bag | MCC25321 | 6-91730-17104-9 | 5/17/2027 |
The product was distributed through retail stores in Colorado, Utah, Washington, Oregon, Pennsylvania, Rhode Island, Michigan, California, Texas, Illinois, Georgia, North Carolina, South Carolina, Florida, Minnesota, New York, Ohio, Wisconsin, Idaho, and Montana.
Thiamine is an essential water-soluble vitamin required for normal carbohydrate metabolism and neurologic function in both cats and dogs. While thiamine deficiency can occur in either species, cats are considered more susceptible due to their higher dietary requirement and limited capacity to compensate for inadequate intake.
Pets consuming a thiamine-deficient diet over an extended period may develop early signs including decreased appetite, vomiting, excessive salivation, weight loss, or poor growth. As deficiency progresses, neurological signs may develop, such as ventroflexion of the neck—bending the head toward the floor—mental dullness, vision changes, wobbly walking, circling, falling, and seizures. In severe or prolonged cases, thiamine deficiency may progress to profound weakness and lethargy, and without intervention, advanced deficiency can be life-threatening.
Pet owners are advised to contact their veterinarian if they observe any concerning clinical signs. When recognized early and treated appropriately, thiamine deficiency is generally reversible, and most animals respond well to supplementation and supportive care.
Go Raw LLC stated that all current Steve’s Real Food products are being manufactured using updated formulations that include a new vitamin premix, and these are the only formulations currently being distributed to retailers and consumers.
As part of the investigation, the company worked closely with distributors and retailers and confirmed that the affected lot is no longer present in distribution channels. The recall was initiated out of an abundance of caution, the company said.
During its investigation, Go Raw gained insights into the complexities of thiamine stability and analytical testing. The company noted that thiamine is a sensitive nutrient and that testing results can vary significantly, even in products formulated with elevated levels. The company continues to work with the U.S. Food and Drug Administration and industry experts to better understand testing methodologies and support ongoing research.
Consumers who have purchased the affected product are urged to stop feeding it to their pets and return it to the place of purchase for a full refund or replacement.
Customers with questions may contact Go Raw LLC directly at cs@gorawllc.com or call 801-432-7478, Monday through Friday from 9:00 AM to 4:00 PM Mountain Standard Time.
BD Recalls Skin Prep Applicators Over Fungal Contamination Risk
FRANKLIN LAKES, N.J. – June 6, 2026 – BD (Becton, Dickinson and Company) has issued a nationwide voluntary recall of specific lots of ChloraPrep™ Clear Single Sterile 1 mL and FREPP™ Clear 1.5 mL applicators due to potential fungal contamination, the company announced Friday.
The recall affects lot 4032183 of ChloraPrep Clear 1 mL Single Sterile and lot 4073005 of FREPP Clear 1.5 mL applicators with paper lidding. The impacted lots were shipped to distributors and hospitals between March 2024 and June 2024.
The products are packaged in a pouch with paper lidding and are used for the preparation of a patient’s skin prior to procedures to help reduce bacteria that can potentially cause skin infection.
According to BD, the recall was initiated due to fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides. Contamination of skin preparation products with this fungus may lead to serious systemic infection, sepsis, illness, and death. If the fungus is introduced into a patient’s bloodstream during placement of an intravascular catheter, the catheter would most likely need to be removed, necessitating an additional procedure. Infection at a surgical site may result in the need for medical and surgical interventions and long-term treatment with antifungal drugs.
| Affected Product NDC | Product Name | Catalog (REF) Number | Lot Number | Expiry Date | Product Package Size |
|---|---|---|---|---|---|
| 54365-400-31 | BD ChloraPrep™ Clear – 1 mL Applicators | 930480 | 4032183 | 01/31/2027 | 60 Applicators per Inner Carton |
| 54365-400-30 | BD ChloraPrep™ FREPP™ Clear 1.5 mL Applicators | 930299 | 4073005 | 03/31/2027 | 20 Applicators per Inner Carton |
BD stated that it has not received any reports of adverse events related to this recall. However, the company is also recalling other lots out of an abundance of caution, as outlined in the customer letter.
The affected lots can be identified by locating the referenced catalog and lot numbers on the lidding of the product package and the side of the inner carton.
BD is notifying customers and distributors who received the product directly. Customers and distributors are instructed to immediately discontinue use of and destroy all affected units in accordance with their facility’s process.
BD will issue replacement product for destroyed affected lots to customers who purchased directly from BD, following receipt of the completed Customer Response Form.
Customer inquiries related to this recall, as well as adverse reaction or events experienced with the product, should be addressed to BD’s North American Regional Complaint Center at 1-844-823-5433, Monday through Friday between 8:00 AM and 5:00 PM CT, or by emailing productcomplaints@bd.com.
Adverse reactions or events should also be reported to the FDA’s MedWatch Adverse Event Reporting program online, by phone, or by regular mail.
The U.S. Food and Drug Administration has been notified of this recall.
About the Author
